HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)

ConditionHIV Infection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorANRS, Emerging Infectious Diseases

About this trial

The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.

Eligibility criteria

Qualifiers

All available samples tested positive for HIV during the national Health survey of Cameroon in 2011 And 2018

All Individuals who came to Centre Pasteur in Yaoundé or Garoua for HIV screening or viral load monitoring.

Disqualifiers

Insufficient quantity or degraded Dried Blood Spot samples

All HIV-positive individuals aged less than 21 years, infected with a Group M HIV-1 virus, or those who refused to participate in the study

Trial design

Treatments tested in this trial

  • Prospective

Treatment groups

220 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

ANRS, Emerging Infectious Diseases

Lead sponsor

University Hospital, Rouen

Collaborator

Centre Pasteur du Cameroun

Collaborator